Filing Details

Accession Number:
0001209191-12-054666
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-27 17:36:46
Reporting Period:
2012-11-26
Filing Date:
2012-11-27
Accepted Time:
2012-11-27 17:36:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1254419 Medassets Inc MDAS Services-Prepackaged Software (7372) 510391128
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1415810 A John Bardis 100 North Point Center East
Suite 200
Alpharetta GA 30022
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-26 16,630 $2.86 1,082,326 No 4 M Direct
Common Stock Acquisiton 2012-11-26 54,201 $9.68 1,136,527 No 4 M Direct
Common Stock Acquisiton 2012-11-26 44,800 $9.29 1,181,327 No 4 M Direct
Common Stock Disposition 2012-11-26 50,000 $16.39 1,131,327 No 4 S Direct
Common Stock Disposition 2012-11-27 50,000 $16.61 1,081,327 No 4 S Direct
Common Stock Disposition 2012-11-27 7,550 $16.64 1,073,777 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2012-11-26 16,629 $0.00 16,630 $2.86
Common Stock Stock Options (Right to Buy) Disposition 2012-11-26 34,200 $0.00 34,201 $9.68
Common Stock Stock Options (Right to Buy) Disposition 2012-11-26 20,000 $0.00 20,000 $9.68
Common Stock Stock Options (Right to Buy) Disposition 2012-11-26 24,800 $0.00 24,800 $9.29
Common Stock Stock Options (Right to Buy) Disposition 2012-11-26 20,000 $0.00 20,000 $9.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-09-14 No 4 M Direct
0 2016-07-05 No 4 M Direct
0 2016-10-01 No 4 M Direct
0 2017-09-10 No 4 M Direct
0 2017-09-10 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,000 Indirect By Spouse
Common Stock 112,378 Indirect By Bardis Children 2007 Trust
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock-Settled Stock Appreciation Rights $14.74 2016-01-05 121,542 121,542 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-01-05 121,542 121,542 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.22 to $16.57, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.19 to $16.81, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.48 to $16.80, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
  4. The reporting person was granted these options on September 14, 2005 and are fully vested.
  5. The reporting person was granted these options on July 5, 2006 and are fully vested.
  6. The reporting person was granted these options on October 1, 2006 and are fully vested.
  7. The reporting person was granted these options on September 10, 2007 and are fully vested.
  8. The reporting person was granted these stock-settled stock appreciation rights (SSARs) on January 5, 2009. The SSARs vest 25% annually beginning on December 31, 2009 such that 100% of the SSARs will be fully vested on December 31, 2012.